Hanné Andersen

16.7k total citations · 3 hit papers
49 papers, 2.5k citations indexed

About

Hanné Andersen is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Hanné Andersen has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 21 papers in Immunology and 18 papers in Epidemiology. Recurrent topics in Hanné Andersen's work include SARS-CoV-2 and COVID-19 Research (14 papers), Influenza Virus Research Studies (10 papers) and Immunotherapy and Immune Responses (9 papers). Hanné Andersen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), Influenza Virus Research Studies (10 papers) and Immunotherapy and Immune Responses (9 papers). Hanné Andersen collaborates with scholars based in United States, Denmark and Italy. Hanné Andersen's co-authors include Srinivas S. Rao, Gary J. Nabel, Mark G. Lewis, Chih‐Jen Wei, Wing-Pui Kong, Patrick M. McTamney, Jeffrey C. Boyington, Stephen Higgs, Terrence M. Tumpey and Wing‐Pui Kong and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Hanné Andersen

47 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

2015 515 citations Jeffrey C. Boyington, Patrick M. McTamney et al. profile →
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

2021 230 citations Jiří Zahradník, Shir Marciano et al. Nature Microbiology profile →
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters

2022 119 citations Katherine McMahan, Victoria Giffin et al. Med profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanné Andersen United States	20	1.3k	1.1k	744	548	461	49	2.5k
Julie E. Ledgerwood United States	28	1.3k 1.0×	1.1k 1.0×	756 1.0×	416 0.8×	715 1.6×	53	2.6k
Julie Furze United Kingdom	23	783 0.6×	1.3k 1.2×	737 1.0×	464 0.8×	212 0.5×	27	2.2k
Ian J. Amanna United States	22	960 0.8×	896 0.8×	1.3k 1.7×	716 1.3×	408 0.9×	42	3.0k
Geetha P. Bansal United States	17	1.6k 1.2×	1.4k 1.3×	674 0.9×	707 1.3×	209 0.5×	43	2.8k
Fabiana Falugi Italy	20	950 0.8×	1.4k 1.3×	479 0.6×	988 1.8×	791 1.7×	25	3.5k
Wing‐Pui Kong United States	19	1.4k 1.1×	894 0.8×	392 0.5×	491 0.9×	426 0.9×	26	2.6k
Larissa Kolesnikova Germany	37	2.5k 2.0×	1.2k 1.1×	379 0.5×	663 1.2×	200 0.4×	63	3.4k
Robin Bombardi United States	22	882 0.7×	624 0.6×	392 0.5×	517 0.9×	498 1.1×	35	1.7k
Ashley J. Birkett United States	22	443 0.4×	1.3k 1.2×	887 1.2×	606 1.1×	410 0.9×	36	2.3k
Nigel Temperton United Kingdom	33	1.8k 1.4×	1.9k 1.8×	961 1.3×	736 1.3×	305 0.7×	124	3.9k

Countries citing papers authored by Hanné Andersen

Since Specialization

Citations

This map shows the geographic impact of Hanné Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanné Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanné Andersen more than expected).

Fields of papers citing papers by Hanné Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanné Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanné Andersen. The network helps show where Hanné Andersen may publish in the future.

Co-authorship network of co-authors of Hanné Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Hanné Andersen. A scholar is included among the top collaborators of Hanné Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanné Andersen. Hanné Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sui, Yongjun, et al.. (2025). Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters. Frontiers in Immunology. 16. 1514845–1514845.

Nkolola, Joseph P., David Hope, Malika Aïd, et al.. (2024). Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques. Journal of Virology. 98(12). e0142924–e0142924.

Pal, Ranajit, et al.. (2024). Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates. Vaccine. 42(5). 1122–1135. 5 indexed citations

Sui, Yongjun, Hanné Andersen, Bianca M. Nagata, et al.. (2023). SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy. Vaccine. 42(2). 339–351. 1 indexed citations

Wong, Teri Ann S., Michael M. Lieberman, Chih-Yun Lai, et al.. (2022). Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80–Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human Primates. Journal of Pharmaceutical Sciences. 111(12). 3424–3434. 1 indexed citations

McMahan, Katherine, Victoria Giffin, Lisa H. Tostanoski, et al.. (2022). Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters. Med. 3(4). 262–268.e4. 119 indexed citations breakdown →

Rosati, Margherita, Mahesh Agarwal, Xintao Hu, et al.. (2021). Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques. PLoS Pathogens. 17(9). e1009701–e1009701. 12 indexed citations

He, Xuedan, Ali Zhang, Jann C. Ang, et al.. (2021). A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge. Proceedings of the National Academy of Sciences. 118(22). 27 indexed citations

Baczenas, John J., et al.. (2021). Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike. Viruses. 13(12). 2434–2434. 19 indexed citations

10.

Zahradník, Jiří, Shir Marciano, Maya Shemesh, et al.. (2021). SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nature Microbiology. 6(9). 1188–1198. 230 indexed citations breakdown →

11.

Andersen, Hanné, et al.. (2020). Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus. Antiviral Research. 180. 104753–104753. 2 indexed citations

12.

Medina, Liana, Michael M. Lieberman, Teri Ann S. Wong, et al.. (2018). A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Frontiers in Immunology. 9. 2464–2464. 33 indexed citations

13.

Bagley, Kenneth, Jennifer A. Schwartz, Hanné Andersen, et al.. (2017). An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model. Viral Immunology. 30(3). 178–195. 13 indexed citations

14.

Roy, Chad J., Satheesh K. Sivasubramani, J. Patrick Gorres, et al.. (2011). Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method. Respiratory Research. 12(1). 153–153. 18 indexed citations

15.

Wei, Chih‐Jen, Jeffrey C. Boyington, Patrick M. McTamney, et al.. (2010). Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination. Science. 329(5995). 1060–1064. 277 indexed citations

16.

DiNapoli, Joshua M., Baibaswata Nayak, Lijuan Yang, et al.. (2009). Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys. Journal of Virology. 84(3). 1489–1503. 77 indexed citations

17.

Andersen, Hanné, Eugene V. Barsov, Matthew T. Trivett, et al.. (2007). Transduction with Human Telomerase Reverse Transcriptase Immortalizes A Rhesus Macaque CD8 ⁺ T Cell Clone with Maintenance of Surface Marker Phenotype And Function. AIDS Research and Human Retroviruses. 23(3). 456–465. 18 indexed citations

18.

Barsov, Eugene V., Hanné Andersen, Vicky Coalter, et al.. (2005). Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics☆. Immunology Letters. 105(1). 26–37. 13 indexed citations

19.

Andersen, Hanné, et al.. (2000). Expression of Intracellular IFN-γ in HSV-1-Specific CD8+ T Cells Identifies Distinct Responding Subpopulations During the Primary Response to Infection. The Journal of Immunology. 165(4). 2101–2107. 11 indexed citations

20.

McNally, James M., Hanné Andersen, Robert Chervenak, & Stephen R. Jennings. (1999). Phenotypic Characteristics Associated with the Acquisition of HSV-Specific CD8 T-Lymphocyte-Mediated Cytolytic Function in Vitro. Cellular Immunology. 194(1). 103–111. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact